Total planned funding: $831,840,399
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $186,934,459 |
Kenya | $159,186,810 |
Tanzania | $98,466,118 |
Zambia | $91,181,417 |
Uganda | $71,022,788 |
Mozambique | $36,898,858 |
South Africa | $30,970,763 |
Rwanda | $28,025,490 |
Ethiopia | $25,164,324 |
Zimbabwe | $24,088,562 |
Côte d'Ivoire | $18,138,524 |
Haiti | $16,522,154 |
Democratic Republic of the Congo | $13,686,038 |
Vietnam | $10,078,765 |
Botswana | $8,566,053 |
Eswatini | $6,062,172 |
Ukraine | $2,605,290 |
Guyana | $2,192,864 |
Namibia | $1,215,324 |
Malawi | $650,000 |
South Sudan | $80,453 |
Papua New Guinea | $35,833 |
Central Asia Region | $33,169 |
Cameroon | $27,160 |
Burundi | $4,720 |
Caribbean Region | $2,291 |
Organizational Types
Private Contractor | $510,112,855 |
Unknown | $100,404,534 |
NGO | $77,767,564 |
Host Country Government Agency | $74,957,363 |
FBO | $29,219,774 |
University | $29,135,193 |
Implementing Agency | $4,429,208 |
Own Agency | $3,428,759 |
Other USG Agency | $1,255,016 |
Parastatal | $1,130,133 |
Program Areas
Treatment | $831,840,399 |
Budget Codes
HTXD: Treatment: ARV Drugs | $831,840,399 |